Global Development
The company adheres to global development, actively promotes the construction of the "Belt and Road" and supply-side structural reforms, innovates and improves investment and financing mechanisms, uses global elements, optimizes resource allocation, and actively integrates into the global industrial chain and value chain. At the same time, actively introduce foreign advanced technology, high-quality assets, high-end talents and advanced management experience to Jiangbei to accelerate the company's transformation, upgrading and technological innovation.
The company adheres to the core values of "Valuing customer interests, competing in harmony, and creating value", actively participates in the global industrial re-division of labor, undertakes industrial and capital transfer, expands the international market space, and comprehensively enhances the company's technology, brand, marketing, and service, devoting to build the company into an internationally competitive pharmaceutical company.
International Certifications
| 1 | July 2009 | Simvastatin | EU CEP Certificate |
| 2 | January 2012 | Simvastatin | India Certificate of Registration |
| 3 | February 2012 | Simvastatin | Korea Certificate of Registration |
| 4 | May 2013 | Levetiracetam | Korea Certificate of Registration |
| 5 | June 2013 | Levetiracetam | EU CEP Certificate |
| 6 | July 2013 | Simvastatin（Contains BHA） | EU CEP Certificate |
| 7 | August 2014 | Simvastatin and Simvastatin ammonium salt | Passed the U.S. FDA inspection |
| 8 | March 2015 | Simvastatin | Domestic GMP certification |
| 9 | July 2015 | Simvastatin | German GMP certificate |
| 10 | May 2016 | Atorvastatin Calcium | EU CEP Certificate |
| 11 | May 2016 | Simvastatin | Passed the U.S.FDA inspection |
| 12 | June 2016 | Simvastatin | Russian Certificate of Registration |
| 13 | February 2017 | Atorvastatin Calcium | WC for API Exported to EU |
| 14 | September 2017 | Clopidogrel | EU CEP certificate |
| 15 | January 2018 | Efavirenz | Domestic GMP certification |
| 16 | July 2018 | Simvastatin | WC for API Exported to EU |
| 17 | July 2018 | Simvastatin、Levetiracetam、Efavirenz、Rosuvastatin Calcium 、Clopidogrel、Darunavir 、Atorvastatin Calcium | GMP certificate of the Russian Ministry of Health |
| 18 | August 2018 | Efavirenz, Darunavir | Passed WHO GMP Inspection |
| 19 | August 2018 | Levetiracetam | EU CEP certificate |
| 20 | November 2018 | Simvastatin | CEP certificate |
| 21 | February 2019 | Ibuprofen tablets | UK MHRA GMP Certificate |
| 22 | May 2019 | Levetiracetam | WC for API Exported to EU |
| 23 | June 2019 | Atorvastatin Calcium | EU CEP certificate |
| 24 | November 2019 | Simvastatin，Atorvastatin Calcium, Rosuvastatin Calcium | Domestic GMP certification |
| 25 | February 2020 | Efavirenz Tablets | Passed WHO GMP Inspection |
| 26 | December 2020 | Rosuvastatin Calcium Tablets | Passed Domestic GMP Inspection |
| 27 | December 2021 | Levetiracetam | Passed Domestic GMP Inspection |
| 28 | April 2022 | Atorvastatin Calcium-IM2 process | EU CEP certificate |
| 29 | October 2022 | Levetiracetam, Atorvastatin Calcium, Rosuvastatin Calcium, Rosuvastatin Calcium Tablets, Atorvastatin Calcium Dispersible Tablets | Passed Domestic GMP Inspection |
| 30 | January 2023 | Rosuvastatin Calcium | EU CEP certificate |
| 31 | February 2023 | Darunavir | WC for API Exported to EU |
| 32 | April 2023 | Simvastatin-process II | EU CEP certificate |
| 33 | April 2023 | Simvastatin （contains BHA）-process II | EU CEP certificate |
| 34 | August 2023 | Simvastatin，Atorvastatin Calcium | Passed the U.S.FDA inspection |
| 35 | September 2023 | Simvastatin, Levetiracetam | ANVISA GMP Certification |
Cooperation Content
1. Undertake the customized production of APIs and high-end intermediates for international pharmaceutical enterprises.
2. Undertake the customized production of pharmaceutical preparations for international pharmaceutical companies/medicine distributors.
3.Establish strategic partners in terms of international marketing/commercial trading of pharmaceutical preparations, APIs and intermediates, or co-build a marketing network.
4. Undertake drug and technology development for international customers.
5. Introduce advanced technology, high-quality assets and high-end talents from abroad.
Sales Department Telephone:
Purchasing Department Telephone:
Personnel Department Telephone: